Carbamazepine decreases antihypertensive effect of nilvadipine

Journal of Clinical Pharmacology

Volumn 42, Issue 1, 2002, Pages 100-103

  Yasui Furukori, Norio ^a,b   Tateishi, Tomonori ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Sanraku Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CYTOCHROME P450 3A; HALOPERIDOL; NILVADIPINE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG METABOLISM; ENZYME INDUCTION; HUMAN; HYPERTENSION; MALE; MANIA;

ANTIHYPERTENSIVE AGENTS; ANTIMANIC AGENTS; CARBAMAZEPINE; DRUG INTERACTIONS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE;

EID: 0036139563     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270002042001012     Document Type: Article

References (13)

1. Nilvadipine: A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina
2. Pharmacokinetics of nilvadipine after single oral doses in healthy volunteers
3. Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension
4. 24-Hour blood pressure control after single daily doses of nilvadipine in patients with essential hypertension
5. Pharmacokinetics of nilvadipine
6. Phenobarbital, phenytoin, and carbamazepine
7. Pharmacokinetics of nilvadipine in healthy volunteers
8. Determination of pranoprofen in serum by automated column-switching high-performance liquid chromatography
9. Determination of bromperidol in serum by automated column-switching high-performance liquid chromatography
10. Calcium channel blockers
11. Clinical implications of enzyme induction and enzyme inhibition
12. Induction of drug metabolising enzymes: Pharmacokinetic and toxicological consequences in humans